fda approvals in bladder cancer and nsclc, and 2019 elcc highlights
Published 5 years ago • 286 plays • Length 8:43
Download video MP4
Download video MP3
Similar videos
-
6:59
fda approval in nsclc, priority review in bladder cancer, mbcc highlights, and more
-
8:30
fda approvals in bladder cancer, nsclc, aml, hcc, and a breakthrough designation in nsclc
-
8:05
fda approvals in nsclc, bladder cancer, and breast cancer, and death in car t-cell therapy trial
-
10:18
fda approvals in bladder cancer and hodgkin lymphoma, breakthrough designation in aml, and more
-
6:58
fda approvals in nsclc and soft tissue sarcoma, priority review in bladder cancer, and more
-
9:27
fda approval in bladder cancer, breakthrough therapy designation in dlbcl, and more
-
6:13
fda approval in carcinoid syndrome diarrhea, priority reviews in bladder cancer and nsclc, and more
-
3:19
fda approval of durvalumab for advanced bladder cancer
-
1:49
fda approval of durvalumab for bladder cancer
-
0:31
preview: fda approvals in nsclc and soft tissue sarcoma, priority review in bladder cancer, and more
-
2:03
durvalumab fda approval for bladder cancer
-
9:07
fda approvals in breast cancer and bladder cancer and phase iii data with larotrectinib
-
5:32
fda approval and 2 priority reviews in bladder cancer, and asco's cancer advance of the year
-
7:21
fda approval in breast cancer, breakthrough designations in aml and bladder cancer, and more
-
7:05
the fda approval of atezolizumab in bladder cancer
-
6:49
fda approval of atezolizumab for advanced bladder cancer
-
0:38
dr. petrylak on fda approval of pembrolizumab in bladder cancer
-
13:01
fda approvals in urothelial cancer and prostate cancer, priority review in crc, and more
-
9:10
fda approvals in urothelial cancer and gist, promising data in urothelial carcinoma, and more
Clip.africa.com - Privacy-policy